
Rimegepant for Migraine Prevention: Real-World Evidence
Real-world data on every-other-day rimegepant for prevention and why starting earlier helps.
New studies explained, treatment guides and updates as they happen. Over 290 articles so far, all free to read.

Real-world data on every-other-day rimegepant for prevention and why starting earlier helps.

About 1 in 9 people are pain-free at 2 hours on placebo, and that rate keeps rising.

In a one-year study of nearly 600 people on atogepant, average weight went down.

A large randomized trial found a personalized low-glycemic diet lowered monthly migraine days.

In 36,000 adults, migraine burden rose smoothly with attack frequency, with no chronic cutoff.

A 19-trial meta-analysis looks at whether CGRP preventives like erenumab raise blood pressure.

Real-world data show fremanezumab cut migraine days by nearly 6 a month.

When an attack needs emergency care, what federal law guarantees you in the ER, how the No Surprises Act limits what you owe, and how to…

Blood CGRP was lower in people with migraine, not higher, and did not track with attacks.

What CGRP is, how it drives an attack, and how antibodies and gepants block it.

How sleep and migraine affect each other, the weekend lie-in trap, and when to check for apnea.

How migraine looks in kids and teens, how it is treated, and the red flags to watch for.

Why attacks cluster around your period, and how timed prevention can help.

Brief vision loss in one eye: how retinal migraine is told apart from stroke and treated.

In 130,000 women, a migraine history was tied to modestly higher stroke risk after menopause.

A 199-trial network analysis ranks migraine preventives by effectiveness and tolerability.

Candesartan, a low-cost blood pressure pill, can prevent attacks. Dosing, safety and fit.

The evidence does not support claims that the side of your attacks predicts brain damage.
Comparing products? See the buyer's guides.